Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Argon Pharma discovers new prostaglandin G/H synthase 2 inhibitors

Feb. 24, 2011

Proacta and Yakult Honsha enter PR-509 development agreement

Feb. 24, 2011

Novel tyrosine-protein kinase SYK inhibitors described by IRM

Feb. 24, 2011

Tariquidar is safe in combination with docetaxel in patients with cancer

Feb. 24, 2011

Chugai's anticancer agent Xeloda approved for additional indication in Japan

Feb. 23, 2011

Angiochem receives NBTS innovation award for development of new brain cancer treatments

Feb. 23, 2011

Infinity Pharma begins phase II portion of IPI-926 trial in pancreatic cancer

Feb. 23, 2011

Brusatol suppresses development of resistance to chemotherapeutic agents in vivo

Feb. 23, 2011

MedTrust Online and Avantra partner to validate cancer biomarker assays

Feb. 23, 2011

IST5-002 shows promise in models of prostate cancer

Feb. 23, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...